109 related articles for article (PubMed ID: 25310186)
1. Restoration of microRNA‑218 increases cellular chemosensitivity to cervical cancer by inhibiting cell‑cycle progression.
Dong R; Qiu H; Du G; Wang Y; Yu J; Mao C
Mol Med Rep; 2014 Dec; 10(6):3289-95. PubMed ID: 25310186
[TBL] [Abstract][Full Text] [Related]
2. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
4. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
Dong J; Sui L; Wang Q; Chen M; Sun H
Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells.
Zhang CY; Bao W; Wang LH
Int J Mol Med; 2014 Jun; 33(6):1577-85. PubMed ID: 24714974
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
8. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
Chen J; Zeng J; Xin M; Huang W; Chen X
Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner.
Mou Z; Xu X; Dong M; Xu J
Med Sci Monit; 2016 Aug; 22():2809-15. PubMed ID: 27505047
[TBL] [Abstract][Full Text] [Related]
11. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
[TBL] [Abstract][Full Text] [Related]
12. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X
Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611
[TBL] [Abstract][Full Text] [Related]
13. miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma.
Shi J; Yang L; Wang T; Zhang J; Guo X; Huo X; Niu H
Mol Med Rep; 2013 Oct; 8(4):1111-7. PubMed ID: 23970061
[TBL] [Abstract][Full Text] [Related]
14. MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1.
Li Z; Wang H; Wang Z; Cai H
Tumour Biol; 2016 May; 37(5):6457-63. PubMed ID: 26631043
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
16. circEIF4G2 modulates the malignant features of cervical cancer via the miR‑218/HOXA1 pathway.
Mao Y; Zhang L; Li Y
Mol Med Rep; 2019 May; 19(5):3714-3722. PubMed ID: 30896864
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a.
Wang N; Wei H; Yin D; Lu Y; Zhang Y; Zhang Q; Ma X; Zhang S
Tumour Biol; 2016 Apr; 37(4):4711-20. PubMed ID: 26511972
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.
Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J
Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295
[TBL] [Abstract][Full Text] [Related]
19. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
20. Radiation-inducible protein RbAp48 contributes to radiosensitivity of cervical cancer cells.
Zheng L; Tang W; Wei F; Wang H; Liu J; Lu Y; Cheng Y; Bai X; Yu X; Zhao W
Gynecol Oncol; 2013 Sep; 130(3):601-8. PubMed ID: 23756179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
